Our work

Equitable access to vaccines, diagnostics and treatments for coronavirus (COVID-19)

All R&D funders, developers and manufacturers must help ensure that new vaccines, diagnostics and treatments developed for COVID-19 are globally available, appropriate and affordable, regardless of where they have been developed or who has funded them.


Report Updated 4 December 2019

Exploring terminology and naming for controlled human infection models

DownloadPDF 415KB

The current language used to describe controlled human infection models is complex, with many different names being used. This report highlights what the issues and possible solutions are.